GlassScriptPhysician profile
Brandy L Farmer
NPI 1184998742
$6,550.63
in general payments reported to CMS, 2019-2025
46 companies · $944 in 2025
The $944 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,169 · 2022: $1,399 · 2023: $1,788 · 2024: $1,251 · 2025: $944.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,983.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,983.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $775.34 | 2021-2024 | Mounjaro, Trulicity, Humulin |
| Abbott Laboratories | $759.43 | 2021-2025 | Freestyle Libre 3 |
| Mannkind Corporation | $454.40 | 2021-2025 | Afrezza |
| Novo Nordisk INC | $394.77 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Corcept Therapeutics | $358.62 | 2021-2024 | Korlym |
| Dexcom, INC. | $348.01 | 2021-2024 | Dexcom G6 Transmitter |
| Insulet Corporation | $240.29 | 2021-2025 | Omnipod |
| Sanofi-Aventis U.S. LLC | $224.73 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $222.63 | 2021-2023 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $221.98 | 2021-2024 | |
| Horizon Therapeutics Plc | $210.29 | 2021-2022 | |
| Beta Bionics, INC. | $193.08 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Ibsa Pharma INC. | $169.32 | 2022-2025 | Tirosint, Licart, Tirosint |
| Medtronic, INC. | $156.93 | 2021-2023 | Minimed 780g |
| Cequr Corporation | $156.12 | 2023-2025 | Cequr Simplicity |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amryt Pharma Holdings LTD | $140.28 | 2022-2023 | Mycapssa |
| Abbvie INC. | $139.84 | 2021-2024 | |
| Amgen INC. | $139.13 | 2022-2025 | Tepezza, Repatha, Prolia |
| Recordati_rare_diseases_inc. | $108.77 | 2021-2025 | Isturisa, Signifor Lar |
| Xeris Pharmaceuticals, INC. | $101.45 | 2023-2025 | Recorlev, Gvoke Hypopen |
| Amarin Pharma, INC. | $90.92 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $67.83 | 2021 | |
| Tandem Diabetes Care, INC. | $67.16 | 2022-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Ascensia Diabetes Care US INC. | $60.70 | 2023-2024 | |
| Becton, Dickinson and Company | $59.61 | 2021-2022 | |
| Renalytix Ai, INC. | $52.78 | 2022-2023 | Kidneyintelx Blood Collection Convenience Kit |
| Embecta Corp. | $52.33 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Chiesi USA, INC. | $52.33 | 2024-2025 | Mycapssa, Myalept |
| Nevro Corp. | $51.43 | 2024 | Senza |
| Pfizer INC. | $48.06 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $47.59 | 2021-2022 | |
| Esperion Therapeutics, INC. | $45.66 | 2021 | |
| Clarus Therapeutics INC. | $37.41 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $34.80 | 2021 | |
| Amphastar Pharmaceuticals, INC. | $34.42 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $31.55 | 2022-2023 | |
| Tolmar, INC. | $29.45 | 2023 | |
| Globus Medical, INC. | $23.59 | 2025 | Omnia |
| Takeda Pharmaceuticals U.S.A., INC. | $23.12 | 2021 | |
| Verity Pharmaceuticals INC. | $22.67 | 2025 | Tlando |
| Amneal Pharmaceuticals LLC | $21.76 | 2023 | Unithroid |
| Almatica Pharma LLC | $21.46 | 2025 | Teriparatide |
| Ascendis Pharma Endocrinology INC | $16.19 | 2025 | Yorvipath |
| Acerus Pharmaceuticals Corporation | $16.11 | 2021 | |
| Vistapharm, INC. | $13.73 | 2021 | |
| Acella Pharmaceuticals, LLC | $12.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Farmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.